Eur Rev Med Pharmacol Sci 2022; 26 (22): 8205-8205
DOI: 10.26355/eurrev_202211_30349

Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway

N. Gurkan

Department of Obstetrics and Gynecology, Medical Park Hospital, Samsun, Turkey


The article “Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway, by N. Gurkan, published in Eur Rev Med Pharmacol Sci 2022; 26 (16): 5926-5931–10.26355/eurrev_202208_29532–PMID: 36066168” has been retracted by the author as she stated that Vitamin D was used in the study as supplement and not a drug without the permission of the Ministry. Although Vitamin D is a commonly used supplement during pregnancy, the Local Ethics Committee accepted it as a drug and asked for it to be approved by the Ministry of Health. Therefore, the manuscript has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/29532

Free PDF Download

To cite this article

N. Gurkan
Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 22
Pages: 8205-8205
DOI: 10.26355/eurrev_202211_30349